Akari Therapeutics

NASDAQ: AKTX · Real-Time Price · USD
1.00
0.03 (3.08%)
At close: Aug 15, 2025, 3:58 PM
1.00
0.00%
After-hours: Aug 15, 2025, 04:10 PM EDT

Akari Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-0.00 -0.00 -0.00 -0.00
PEG Ratio
0.00 0.00 0.00 0.00
PS Ratio
n/a n/a n/a n/a
PB Ratio
0.00 -0.07 0.02 0.01
P/FCF Ratio
-0.00 -0.00 -0.00 -0.00
P/OCF Ratio
-0.00 -0.00 -0.00 -0.00
OCF/S Ratio
n/a n/a n/a n/a
Debt / Equity Ratio
0.15 n/a n/a n/a
Quick Ratio
0.15 0.95 1.35 1.91
Current Ratio
0.15 0.95 1.15 1.91
Asset Turnover
n/a n/a n/a n/a
Interest Coverage
88.70 n/a n/a n/a
Return on Equity
-0.89 43.70 -3.89 -3.17
Return on Assets
-0.39 -2.3 -0.5 -1.51
Return on Invested Capital
-0.64 73.39 -5.06 -3.13
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
n/a n/a n/a n/a
Net Profit Margin
n/a n/a n/a n/a
Pretax Profit Margin
n/a n/a n/a n/a
Operating Profit Margin
n/a n/a n/a n/a
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
n/a n/a n/a n/a